Why it matters: California-based cannabis brand Moxie has expanded its operations to Ohio, partnering with Green Investment Partners and Rooted Management Services. This move allows Moxie to bring its premium medical cannabis products to the Ohio market, including its award-winning concentrates, gummies, and new product Caviar Dots. Moxie aims to offer high-quality products at affordable prices to serve the needs of Ohio’s patients.
What they are saying: Gabe Perlow, operator of GIP’s facilities, highlights the emphasis on quality, consistency, and affordability as key pillars of Moxie’s success. The company focuses on producing products that patients and caregivers would want for themselves and their families. Perlow also mentions the replicated model of operations across multiple states, ensuring uniformity and excellent results.
The big picture: Moxie’s expansion into Ohio demonstrates the brand’s growth and commitment to serving medical cannabis patients in different states. By partnering with experienced operators and investing in improving cultivation and processing capabilities, Moxie aims to provide high-quality cannabis products to Ohio patients.
What to watch: Watch for the availability of Moxie’s premium indoor-grown flower in Ohio by the fall of 2023. Additionally, keep an eye on the reception and demand for Moxie’s new product, Caviar Dots, which will be launched in Ohio in July. Monitor how Moxie’s presence in Ohio’s medical cannabis market impacts the industry and competition.
My take: Moxie’s expansion into Ohio is a significant step for the brand and for the medical cannabis market in the state. By leveraging its reputation for high-quality products and partnering with experienced operators, Moxie is well-positioned to meet the needs of Ohio patients. The focus on quality, consistency, and affordability sets Moxie apart, and the replicated model of successful operations ensures a reliable and efficient production process. This expansion aligns with the overall growth and normalization of the cannabis industry, highlighting the increasing acceptance and demand for medical cannabis across different states.
